跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 41 条关于
“SPNpro”
全部
41
临床试验
9
药物
14
机构
2
资讯
16
去年
PROTAC Technology Emerges as Next-Generation Approach for IDO1-Targeted Cancer Immunotherapy
去年
GSK's Oral Carbapenem Antibiotic Tebipenem HBr Succeeds in Phase 3 Trial, Setting Stage for FDA Filing
去年
Spero Therapeutics Halts SPR720 Development After Phase IIa Failure
去年
Spero Therapeutics Investor Lawsuit Dismissed Over FDA Approval Statements
去年
Spero Therapeutics Investor Lawsuit Dismissed Over FDA Feedback on Tebipenem
去年
Spero Therapeutics Prevails in Investor Lawsuit Over Drug Approval Disclosures
去年
Spero Therapeutics' Tebipenem HBr Phase 3 Trial Enrollment Nears Completion
去年
Spero Therapeutics Appoints Esther Rajavelu as President and Chief Executive Officer
去年
Spero Therapeutics' Tebipenem HBr Phase 3 Trial Enrollment on Track; SPR720 Development Suspended
3个月前
Neurovalens Receives FDA De Novo Approval for PTSD Treatment Device Modius Spero
第 1 页,共 2 页
上一页
下一页